Showing results (151-160 of 286) with videos related to

Sort By:
Pageof 29
Gan to Kagaku Ryoho. Cancer & Chemotherapy|March 28, 2019
[Clinicopathological Study of 15 Cases of Primary Duodenal Cancer]Kyosuke Oshima, Kozo Noguchi, Yoshito Tomimaru, et al.
Annals of Surgical Oncology|September 29, 2021
Preoperative FDG-Positive Lymph Nodes Predict the Postoperative Prognosis in Resectable Biliary Tract CancersMasahiko Kubo, Shogo Kobayashi, Kunihito Gotoh, et al.
Annals of Surgical Oncology|March 19, 2024
Skeletal Muscle-Derived Irisin Enhances Gemcitabine Sensitivity and Suppresses Migration Ability in Pancreatic Ductal AdenocarcinomaTomoki Sugimoto, Yoshifumi Iwagami, Shogo Kobayashi, et al.
Annals of Surgical Oncology|September 13, 2024
miR-6855-5p Enhances Radioresistance and Promotes Migration of Pancreatic Cancer by Inducing Epithelial-Mesenchymal Transition via Suppressing FOXA1: Potential of Plasma Exosomal miR-6855-5p as an Indicator of Radiosensitivity in Patients with Pancreatic CancerHiroki Ueda, Hidenori Takahashi, Shogo Kobayashi, et al.
Asian Journal of Endoscopic Surgery|April 8, 2017
Feasibility of laparoscopic cholecystectomy in patients with cerebrospinal fluid shuntTerukazu Yoshihara, Yoshito Tomimaru, Kozo Noguchi, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy|March 4, 2015
[A case report of hepatectomy for liver metastasis of colon cancer after heavy particle radiotherapy]Hideo Tomihara, Naoki Hama, Hiroshi Wada, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy|March 4, 2015
[A case of curatively resected intrahepatic cholangiocarcinoma with hepatic artery and portal vein reconstruction]Yusuke Matsuura, Hiroshi Wada, Yoshito Tomimaru, et al.
Annals of Surgical Oncology|December 27, 2022
Change Impact of Body Composition During Neoadjuvant Chemoradiotherapy in Patients with Resectable and Borderline Resectable Pancreatic Ductal Adenocarcinoma Undergoing PancreatectomyShohei Takaichi, Yoshito Tomimaru, Shogo Kobayashi, et al.
Annals of Surgical Oncology|September 3, 2010
Tyrosine kinase inhibitor PTK/ZK enhances the antitumor effects of interferon-α/5-fluorouracil therapy for hepatocellular carcinoma cellsMasahiro Murakami, Shogo Kobayashi, Shigeru Marubashi, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy|December 29, 2009
[A long-term survival case of hepatocellular carcinoma with lymph node metastasis on the posterior surface of the pancreas head and portal vein tumor thrombus successfully treated with hepatopancreatoduodenectomy and adjuvant interferon-alpha and 5-fluorouracil combination therapy]Yoshito Tomimaru, Shogo Kobayashi, Hiroaki Nagano, et al.
Pageof 29